Comparing ASP Isotopes (ASPI) and Its Peers

ASP Isotopes (NASDAQ:ASPI) is one of 17 public companies in the “Miscellaneous chemical products” industry, but how does it contrast to its competitors? We will compare ASP Isotopes to similar companies based on the strength of its profitability, dividends, earnings, institutional ownership, risk, analyst recommendations and valuation.

Insider & Institutional Ownership

1.5% of ASP Isotopes shares are owned by institutional investors. Comparatively, 79.4% of shares of all “Miscellaneous chemical products” companies are owned by institutional investors. 14.8% of shares of all “Miscellaneous chemical products” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares ASP Isotopes and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	N/A	-116.87%	-90.49%
ASP Isotopes Competitors	-22.44%	7.97%	-6.26%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for ASP Isotopes and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	0	0	0	0	N/A
ASP Isotopes Competitors	19	313	283	4	2.44

As a group, “Miscellaneous chemical products” companies have a potential upside of 15.21%. Given ASP Isotopes’ competitors higher probable upside, analysts clearly believe ASP Isotopes has less favorable growth aspects than its competitors.

Earnings and Valuation

This table compares ASP Isotopes and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
ASP Isotopes	N/A	-$4.95 million	-2.95
ASP Isotopes Competitors	$1.35 billion	$38.41 million	14.43

ASP Isotopes’ competitors have higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

ASP Isotopes competitors beat ASP Isotopes on 8 of the 9 factors compared.

About ASP Isotopes

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.